MWNA
REPL icon

Marshall Wace North America’s Replimune Group REPL Stock Holding History

Marshall Wace North America’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-338,179
Closed -$3.37M – 1423
2020
Q1 		$3.37M Buy
338,179
+208,838
+161% +$3.11M 0.03% 387
2019
Q4 		$1.86M Buy
+129,341
New +$1.86M 0.01% 595

Other funds holding REPL

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Marshall Wace North America's REPL Position: Q2 2020 in Review

Marshall Wace North America sold out of Replimune Group (REPL) in Q2 2020, closing a stake of 338,179 shares — an estimated $3.37M sold.

Marshall Wace North America first reported a position in REPL in Q4 2019 and held it in 2 quarters. The position peaked at $3.37M in Q1 2020. 77 funds tracked by Wall St. Rank hold REPL as of Q2 2020.

  • Marshall Wace North America reported no remaining Replimune Group position as of Q2 2020 after selling out during the quarter.
  • Marshall Wace North America sold 338,179 Replimune Group shares in Q2 2020, an estimated $3.37M.
  • Marshall Wace North America first reported a position in Replimune Group in Q4 2019 and held it in 2 quarters.
  • Marshall Wace North America's Replimune Group position peaked at $3.37M in Q1 2020.
  • 77 funds tracked by Wall St. Rank held Replimune Group as of Q2 2020.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.